BELLEVUE ASSET MANAGEMENT, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

Back to all holdings Add to watchlist

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$57,688
-18.7%
10,5850.0%0.04%
-13.3%
Q2 2023$70,919
-24.1%
10,5850.0%0.04%
-28.6%
Q1 2023$93,466
+18.5%
10,5850.0%0.06%
+3.3%
Q4 2022$78,842
+2.4%
10,585
-1.5%
0.06%
+1.7%
Q3 2022$77,000
-9.4%
10,7470.0%0.06%
-1.6%
Q2 2022$85,000
-44.1%
10,7470.0%0.06%
-34.4%
Q1 2022$152,000
-49.7%
10,7470.0%0.09%
-47.8%
Q4 2021$302,000
-18.6%
10,747
-1.4%
0.18%
-21.6%
Q3 2021$371,000
-14.3%
10,897
+2.9%
0.23%
-14.0%
Q2 2021$433,000
+0.7%
10,5870.0%0.26%
-1.1%
Q1 2021$430,000
-35.9%
10,587
+1.6%
0.27%
-35.0%
Q4 2020$671,000
+32.3%
10,4250.0%0.41%
+16.1%
Q3 2020$507,000
+0.6%
10,4250.0%0.35%
-31.5%
Q2 2020$504,000
+50.4%
10,4250.0%0.52%
+48.6%
Q1 2020$335,000
+4087.5%
10,425
+3690.9%
0.35%
+5700.0%
Q4 2019$8,000–275–0.01%–
 Download
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders